Cyient Ltd
Q1 FY26 Earnings Call Analysis
IT - Services
margin: Category 1orderbook: Yesfundraise: Yescapex: Yesrevenue: Category 4
💰fundraise
Any current/future new fundraising through debt or equity?
- Cyient Semiconductor, a step-down subsidiary of Cyient Limited, is planning a new fundraising.
- The fundraise will be a combination of debt and equity.
- The purpose is to support growth and working capital needs of the semiconductor business.
- Initial equity dilution targeted is relatively small, not exceeding 10-12%.
- Engagement with bankers is ongoing, and final details will be shared once approved.
- This fundraising is separate from Cyient Limited’s buyback program and is focused solely on the semiconductor business.
- The Board has approved the buyback of shares by Cyient Limited but the promoters will not participate, reflecting confidence in the company’s value.
- No immediate large-scale fundraise mentioned for Cyient Limited's core business.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Cyient is making strategic investments in its semiconductor business, which have impacted margins but are intentional for long-term growth.
- The company plans to raise capital (up to ~10-12% dilution) specifically for Cyient Semiconductor to reach breakeven and fund growth.
- Cyient has paused a large-scale strategic acquisition (Project Astro) due to rapid AI evolution and geopolitical uncertainties; decision to proceed is pending.
- Continued investments in AI and digital platforms (e.g., Agentic platform, Engineering Intelligence platform) to transform service lines and drive future growth.
- Sustained fiber build-out spend in North America and EMEA for the next 3 to 5 years, aligned with large customer network expansion plans.
- Significant focus on capex and capital discipline with buyback announced, which is among the largest in the tech sector reflecting strong cash flow confidence.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Cyient expects mid- to high single-digit organic revenue growth year-over-year in FY27.
- Growth will be driven by strength in two to three key markets.
- Despite current market dynamics, confidence remains that these markets will produce enough strength to achieve growth targets.
- Some deal delays impacted Q4 revenue but are expected to normalize, with specific pushbacks in connectivity projects already underway.
- Large deals pipeline is increasing across 5 out of 7 market segments, notably led by connectivity and healthcare, with expansion into other markets anticipated.
- Strategic initiatives, including AI and digital transformations, are expected to support future growth.
- Semiconductor business is projected to reach about $100 million in revenue, though margins will still be negative due to ongoing investments.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Cyient aspires to achieve mid- to high single-digit organic revenue growth year-over-year in FY27.
- The target is to reach a 15% EBIT margin by Q4 of FY27, which translates to approximately 17-17.5% EBITDA margin.
- Margin expansion levers include price hikes, cost savings through automation and AI, administrative cost reductions, and forex tailwinds.
- AI is seen as an opportunity to enhance cost efficiency and drive structured growth across service lines.
- Despite near-term volatility from geopolitical factors, Cyient remains confident in achieving its growth and margin targets.
- The semiconductor business is expected to grow towards a $100 million revenue scale in FY27 but will remain margin negative due to ongoing investments.
- The company plans continued strategic investments and a cautious approach given evolving market dynamics and AI impact.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- In H2 FY26, order intake grew by 5.5% year-over-year compared to H2 FY25.
- Q4 order intake saw a strong 23% growth over the previous year.
- Large deals are increasing across 5 out of 7 market segments, with leadership from connectivity and healthcare.
- Order book for Cyient DLM is at its highest historical level with a book-to-bill ratio of 1.5x.
- Typically, about 75% of order intake/order book converts to revenue within 9 months.
- Some specific deals delayed start from Q4 FY26 to Q1 FY27 but are limited and will not impact the full-year outlook.
- Pipeline continues to grow as a percentage of new business each quarter, indicating robust future funnel.
